Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early emergency-department tirofiban before primary PCI for STEMI
IRCT201105126463N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tirofiban in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Early TIMI flow. Started Mar 2011; status: completed.
02
Drugs
tirofiban
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on IRCT201105126463N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201105126463N1.